J. Goldman & CO LP Bristol Myers Squibb CO Put Options Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $3.97 Million - $5.18 Million
100,000 New
100,000 $5.18 Million
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $1.11 Million - $1.24 Million
17,500 New
17,500 $1.12 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $8,775 - $5.19 Million
-67,500 Reduced 57.45%
50,000 $3.56 Million
Q2 2022

Aug 15, 2022
BUY
$72.62 - $79.98 $8.53 Million - $9.4 Million
117,500 New
117,500 $9.05 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email